bio event
projected target for pharma is close to $ 300 billion and for biotech, it is $ 100 billion. Therefore, the combined target by 2025 is $ 400 billion. I see India as a leader. We are currently around $ 35 billion, we need to get to $ 100 billion soon and this would propel manufacturing and employment. People forget that by doing this, a huge social infrastructure will also develop around it, which is good for the country and its general economy."
“ Typically small organizations do research and get sold off to big MNCs after they achieve some success. I feel this model will be broken shortly. We have to bear in mind the need for healthy regulation. Between intent and delivery of technology, public attitude has determined the implementation of the technology. Each type of innovation can have incremental, disruptive or destructive effect.
“
Presence of lot of undiagnosed people is a major issue that requires attention. So the challenge is to identify such population and prevent NCDs. To diagnose, we require more equipment in public health sector.
Evidence based technology should not fall prey to the fear mongering. The reaction should be based on logic not emotional responses. We are looking forward to work with the NITI Aayog to together work towards a stronger Indian bioeconomy by 2025,” added Mr Murali."
Talking about the major objective behind the event, Dr Kiran Mazumdar-Shaw, Honorary Non Executive Chairman of ABLE, and CMD at Biocon mentioned, " The conclave aims to create a nationwide awareness of the economic potential of Biotechnology across various sectors viz Healthcare, Agriculture, Energy and Sustainable solutions for Industry. It also aims to bring policy makers, the Departments of Biotechnology, the ministries of Health, Food & Agriculture, Environment, the Department of Industrial Policy & Promotion( DIPP), and NITI Aayog onto a common platform."
Mr G S Krishnan, Regional President, Novozymes, India in his comments told BioVoice News,” BioEconomy Conclave event has been held at the right time, especially when there is lot of attention for sustainable solutions from the government. In the industrial biotech segment we covered, food, textile, detergent and bionergy. We see a big opportunity for growth.”
26
BioVoiceNews | December 2016- January 2017